Stay updated on TMB & Neoantigen Relationship in Melanoma & Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the TMB & Neoantigen Relationship in Melanoma & Bladder Cancer Clinical Trial page.
Latest updates to the TMB & Neoantigen Relationship in Melanoma & Bladder Cancer Clinical Trial page
- Check4 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.1%
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements in the latest release.SummaryDifference0.1%
- Check32 days agoChange DetectedThe website has removed the 'Last Update Posted (Estimated)' and added a definitive 'Last Update Posted' feature.SummaryDifference0.0%
- Check39 days agoChange DetectedNew treatment protocols for melanoma and bladder cancer patients have been added, detailing dosing schedules for nivolumab and ipilimumab, while previous entries regarding these treatments have been removed.SummaryDifference7%
- Check47 days agoChange DetectedThe study has been updated to version v2.10.0, with 5 locations now included, replacing the previous version v2.9.7.SummaryDifference0.3%
- Check54 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
Stay in the know with updates to TMB & Neoantigen Relationship in Melanoma & Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TMB & Neoantigen Relationship in Melanoma & Bladder Cancer Clinical Trial page.